Manifestation of multiple sclerosis with paranoid-hallucinatory psychosis [5]

Journal of Neurology

Volumn 253, Issue 4, 2006, Pages 531-532

  Reimer, J ^a   Aderhold, V ^a   Lambert, M ^a   Haasen, C ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ZIPRASIDONE;

ADULT; CASE REPORT; EVOKED MUSCLE RESPONSE; FEMALE; HALLUCINATION; HUMAN; LETTER; MENTAL DISEASE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOID PSYCHOSIS; PRIORITY JOURNAL; PSYCHOSIS; SODIUM RESTRICTION;

ADULT; ANTIPSYCHOTIC AGENTS; DIET; EPILEPSY, GENERALIZED; FEMALE; HALLUCINATIONS; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTHYROIDISM; LORAZEPAM; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PARANOID DISORDERS; PIPERAZINES; PSYCHOTIC DISORDERS; QUINOLONES;

EID: 33745656174     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-005-0024-8     Document Type: Letter

References (15)

1. Chong SA, Ko SM (1997) Clozapine treatment of psychosis associated with multiple sclerosis. Can J Psychiatry 42:90-91
2. Davids E, Hartwig U, Gastpar M (2004) Antipsychotic treatment of psychosis associated with multiple sclerosis. Prog Neuropsychopharmacol Biol Psychiatry 28:743-744
3. Decaux G, Soupart A (2003) Treatment of symptomatic hyponatremia Am J Med Sci 326:25-30
4. Dieterle L, Staudacher T (1998) Schizophrenialike psychosis with polydipsia and electrolyte decompensation in multiple sclerosis (Article in German). Nervenarzt 69:698-701
5. Emsley R, Oosthuizen P (2004) Evidence-based pharmacotherapy of schizophrenia. Int J Neuropsychopharmacol 7:219-238
6. Feinstein A, du Boulay G, Ron MA (1992) Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. Br J Psychiatry 161:680-685
7. Hedges D, Jeppson K, Whitehead P (2003) Antipsychotic medication and seizures: a review. Drugs Today 39:551-557
8. Moreau T, Sochurkova D, Lemesle M, Madinier G, Billiar T, Giroud M, Dumas R (1998) Epilepsy in patients with multiple sclerosis: radiological-clinical correlations. Epilepsia 39:893-896
9. Naber D, Lambert M (2004) Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Prog Neuropsychopharmacol Biol Psychiatry 28:1213-1219
10. Pisiur-Strehlow B, Poser S, Felgenhauer K (1988) Paranoid-hallucinatory psychosis as a manifestation of multiple sclerosis (Article in German). Nervenarzt 59:621-623
11. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:231-237
12. Safferman AZ, Kane JM, Aronowitz JS, Gordon MF, Pollack S, Lieberman JA (1994) The use of clozapine in neurologic disorders. J Clin Psychiatry 55(9):98S-101S
13. Schifferdecker M, Krahl A, Krekel NO (1995) Psychoses in multiple sclerosis - a re-evaluation (Article in German). Fortschr Neurol Psychiatr 63:310-319
14. Sokic DV, Stojsavljevic N, Drulovic J, Dujmovic I, Mesaros S, Ercegovac M, Peric V, Dragutinovic G, Levic Z (2001) Seizures in multiple sclerosis. Epilepsia 42:72-79
15. Stevens JR (1998) Schizophrenia and multiple sclerosis. Schizophr Bull 14:231-241